SCHEMBL3539286

SCHEMBL3539286

CC1CCN(c2nc(N3CCN(C(=O)CN4CCOCC4)CC3)ccc2[N+](=O)[O-])CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.53
KMT2A Q03164 1/20 0.53
ALDH1A1 P00352 6/20 0.52
KDM4E B2RXH2 1/20 0.52
RECQL P46063 1/20 0.52
MAPT P10636 7/20 0.47
MAPK1 P28482 3/20 0.47
POLB P06746 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.43
TSHR P16473 2/20 0.43
GPR174 Q9BXC1 1/20 0.43
NPSR1 Q6W5P4 2/20 0.42
SMO Q99835 1/20 0.41
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41
LMNA P02545 2/20 0.40
GAA P10253 1/20 0.40
HTT P42858 1/20 0.40
TLR8 Q9NR97 1/20 0.39
TLR7 Q9NYK1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3537014 0.96 MAPT (0.48) TDP1KMT2AALDH1A1KDM4ERECQL
SCHEMBL3539569 0.87 MAPT (0.46) TDP1KMT2AALDH1A1KDM4ERECQL
SCHEMBL3540736 0.85 ALDH1A1 (0.55) TDP1KMT2AALDH1A1KDM4ERECQL
SCHEMBL3536204 0.84 MAPT (0.53) TDP1KMT2AALDH1A1KDM4EMAPT
SCHEMBL3534730 0.81 ALDH1A1 (0.50) TDP1KMT2AALDH1A1KDM4ERECQL
Trifluoroacetic Acid SCHEMBL3542661 0.79 ALDH1A1 (0.49) TDP1KMT2AALDH1A1KDM4ERECQL
SCHEMBL5188971 0.78 ALDH1A1 (0.55) TDP1KMT2AALDH1A1KDM4ERECQL
SCHEMBL3539291 0.78 MAPT (0.63) TDP1KMT2AALDH1A1MAPTMAPK1
SCHEMBL13767720 0.75 CSF1R (0.56) KMT2AALDH1A1KDM4ERECQLMAPT
SCHEMBL3537287 0.75 GPR174 (0.47) TDP1KMT2AALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7705042-B2 Class of arylamide compounds useful as inhibitors of c-fms kinase JANSSEN PHARMACEUTICA NV (BE) 2010-04-27 US disclosed
US-7705042-B2 Class of arylamide compounds useful as inhibitors of c-fms kinase JANSSEN PHARMACEUTICA NV (BE) 2010-04-27 US disclosed
US-7705042-B2 Class of arylamide compounds useful as inhibitors of c-fms kinase JANSSEN PHARMACEUTICA NV (BE) 2010-04-27 US disclosed
EP-1807407-B1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA NV (BE) 2009-07-29 EP disclosed
EP-1807407-B1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA NV (BE) 2009-07-29 EP disclosed
EP-1807407-A1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA N.V. (BE) 2007-07-18 EP disclosed
US-20060100201-A1 Inhibitors of c-fms kinase JANSSEN PHARMACEUTICA, N.V. (BE) 2006-05-11 US disclosed
WO-2006047504-A1 AROMATIC AMIDES AS INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA, N.V. (BE) 2006-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060100201-A1 Inhibitors of c-fms kinase MUSK, FLT3, FES TDP1 2371/4885KMT2A 911/4885ALDH1A1 4796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.